Systemic Mastocytosis
📧 Sign up to get email alerts when something new happens for Systemic Mastocytosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-09-20Clinical Trial Update: Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis [Phase 2]
Phase 2 trial of ibrutinib in advanced systemic mastocytosis was terminated with posted results in 2018.
-
FDA approval · 2018-06-21FDA Approved: RYDAPT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approves a supplemental application for RYDAPT (midostaurin) from Novartis Pharmaceuticals; the update expands or modifies the drug’s la…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Stem Cell Transplantation to Treat Systemic Mastocytosis [Phase 2]
An update on a Phase 2 trial evaluating stem cell transplantation as a treatment for systemic mastocytosis. The study status is listed as co…
-
FDA approval · 2017-04-28FDA Approved: RYDAPT — Original Application (Novartis Pharmaceuticals Corporation)
FDA approved RYDAPT (midostaurin) under its original application for an indication in adults with acute myeloid leukemia with FLT3 mutation,…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes [Phase 2]
Phase 2 clinical trial evaluating imatinib mesylate in patients with various activated tyrosine kinase-driven malignancies, including hypere…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-29Clinical Trial Update: Treatment of Indolent Systemic Mastocytosis With PA101 [Phase 2]
A Phase 2 clinical trial evaluating PA101 for indolent systemic mastocytosis has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-29Clinical Trial Update: Imatinib in KIT-negative Systemic Mastocytosis [Phase 4]
The Phase 4 clinical trial evaluating imatinib for KIT-negative systemic mastocytosis has completed. The snippet provides basic trial status…
-
CLINICAL_TRIALS trial_result · 2016-08-29Clinical Trial Update: Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis [Phase 2, Phase 3]
This clinical trial update notes a study evaluating cladribine plus pegylated interferon alfa-2a for systemic mastocytosis in Phase 2 and Ph…
-
FDA approval · 2015-12-03FDA Approved: IMATINIB MESYLATE — Original Application (BluePoint Laboratories)
FDA approved the original application for Imatinib Mesylate from BluePoint Laboratories (ANDA078340), authorizing a generic version of the c…
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: Phase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia [Phase 2]
Phase 2 trial update for midostaurin in aggressive systemic mastocytosis and mast cell leukemia has completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis [Phase 2]
A Phase 2 clinical trial evaluated tanespimycin (17-N-Allylamino-17-Demethoxygeldanamycin) in patients with systemic mastocytosis; the study…
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM) [Phase 2]
Phase 2 clinical trial update for Ontak (denileukin diftitox) in patients with systemic mastocytosis and leukemia. The study status is compl…
-
CLINICAL_TRIALS trial_result · 2011-04-29Clinical Trial Update: Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis [Phase 2]
Phase 2 trial results update evaluating everolimus (RAD001) as therapy for patients with systemic mastocytosis.
-
CLINICAL_TRIALS trial_result · 2011-04-25Clinical Trial Update: Obatoclax for Systemic Mastocytosis [Phase 2]
Phase 2 trial of obatoclax for systemic mastocytosis (with leukemia) was terminated; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: Evaluation of Response of Dasatinib to Treat Mastocytosis [Phase 2]
A Phase 2 trial is evaluating dasatinib for systemic mastocytosis; the current update provides no results or status details.
-
CLINICAL_TRIALS trial_result · 2007-12-13Clinical Trial Update: Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals
This clinical trial update compares cytokine production patterns in patients with systemic mastocytosis to those in individuals with atopic …